Modeling the impact of SARS-CoV-2 variants and vaccines on the spread of COVID-19
DOI10.1016/j.cnsns.2021.105937zbMath1470.92340OpenAlexW3176980150MaRDI QIDQ2045983
M. R. Ferrández, M. Vela-Pérez, A. B. Kubik, Angel Manuel Ramos, Benjamin Ivorra
Publication date: 16 August 2021
Published in: Communications in Nonlinear Science and Numerical Simulation (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1016/j.cnsns.2021.105937
effective reproduction number\(\theta\)-SIR type model501.V2COVID-19 vaccinesSARS-CoV-2 variantsVOC 202012/01
Epidemiology (92D30) Medical epidemiology (92C60) Mathematical modeling or simulation for problems pertaining to biology (92-10)
Related Items (10)
Uses Software
Cites Work
- Be-CoDiS: a mathematical model to predict the risk of human diseases spread between countries -- validation and application to the 2014--2015 ebola virus disease epidemic
- A simple but complex enough \(\theta\)-SIR type model to be used with COVID-19 real data. Application to the case of Italy
- Mathematical modeling of the spread of the coronavirus disease 2019 (COVID-19) taking into account the undetected infections. The case of China
- Unnamed Item
- Unnamed Item
This page was built for publication: Modeling the impact of SARS-CoV-2 variants and vaccines on the spread of COVID-19